|
Reducing the Transmission of HIV in China Clinical Trials Information presented on Clinical Trials Search is not designed to be a substitute for certified medical advice, trips or professional assistance with a real medical doctor. We aren't docs. Always confer with your doctor about Reducing the Transmission of HIV in China conditions. Clinical Trials Search.org is a website committed to listing clinical research studies in human subjects. Reducing the Transmission of HIV in China Clinical research trials and Reducing the Transmission of HIV in China health trials happen in many of cities across the US. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally measure the effectualness of new does drugs. The intention of the studies / projects is to figure out particular human healthcare questions. Clinical trials are a popular manner for doctors, government agencies, and private sector corporations to detect cures for all forms of circumstances, like Reducing the Transmission of HIV in China. Reducing the Transmission of HIV in China Clinical Trials and other clinical trials allow for volunteers to undergo medical treatment options before they are available to the general public. Most times the subjects get treatment for free of charge, and occasionally they are paid for their time. Occasionally there is a cost for a Reducing the Transmission of HIV in China clinical trial. Subjects frequently get the best healthcare possible for their Reducing the Transmission of HIV in China condition. Hazards are a reality, however, and could include more or frequent mD visits, health risks (possibly life-jeopardizing), and/or the treatment being ineffectual. Trials are federally regulated with exacting guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "R" Clinical Trials Conditions > Reducing the Transmission of HIV in China  Reducing the Transmission of HIV in China
Reducing the Transmission of HIV in China
For Condition: HIV Infections
Status: Not yet recruiting
Sponsor(s): National Institute of Allergy and Infectious Diseases (NIAID) ,
Synopsis: This study will evaluate a skills-focused intervention designed to reduce sexual transmission of HIV in China. The program will target HIV infected former plasma donors (FPDs) and injection drug users (IDUs).
Details: Although China is experiencing a rapid spread of the HIV epidemic, prevention efforts have been limited. This project will evaluate an intervention designed to reduce transmission of HIV from two infected groups (FPDs and IDUs) to their partners. Participants will be assigned to either the intervention or a control condition. Participants in both groups will have ongoing access to optional HIV post-test counseling sessions, free high quality condoms, free HIV testing of partners, and free treatment from health care workers trained to treat sexually transmitted infections (STIs) and HIV-related infections. Participants in the intervention condition will participate in eight small-group sessions that will address reducing transmission acts, disclosure of serostatus and testing of partners, coping with stigma and health problems, knowledge of disease progression, and negotiation of health care. Monthly maintenance workshop boosters will be offered to provide social support for 18 months following the intervention. Primary outcome measures will include self-reports of sexual and drug or needle transmission acts, STI incidence, disclosure to and HIV testing of partners, and health-seeking behaviors. Outcome data will be collected at study entry, immediately post-intervention, and 6, 12, and 18 months after the intervention.
Eligibility:
Study Type: Interventional, Prevention, Randomized, Single Blind, Active Control, Parallel Assignment, Efficacy Study
Minimum Age/Maximum Age: 18 Years/59 Years
Genders: Both
Protocol Entry Criteria: Inclusion Criteria - HIV infected - Spouse or fiancé(e) is HIV negative or of unknown HIV status - Participates in high risk transmission behaviors as assessed by questionnaire - Resident of selected study villages in China - Willing and able to take part in the trial and the follow-up
Total Enrollment: 280
Location and Contact Information:
Overall Study Official:
ZunyouWu, Principal Investigator,
Chinese Center for Disease Control and Prevention
Beijing, , 100050
China
Zunyou Wu +86-10-63152573
Additional Information:
Study ID Numbers: 1U19 AI51915-01;
Study Start Date:
Record last reviewed: November 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00068991
Other Hiv Infections Studies:
1. A Study of Patients Who Recently Have Been Infected with HIV
2. A Treatment Protocol for the Use of Trimetrexate With Leucovorin Rescue for AIDS Patients with Pneumocystis carinii Pneumonia and Serious Intolerance to Approved Therapies
3. A Study on the Effect of Chemotherapy Combined with Anti-HIV Drugs in HIV-Positive Patients
4. Comparison of Stavudine Used Alone or in Combination with Didanosine in HIV-Infected Children
5. Active Immunization of HIV-1 Infected, Pregnant Women With CD4 Lymphocyte Counts >= 400/mm3: A Phase I Study of Safety and Immunogenicity of MN rgp120/HIV-1 Vaccine (NOTE: Some Patients Receive Placebo)
Related Studies:
Other HIV Infections Clinical Trials
Other Clinical Trials
Other Beijing Clinical Trials
Reducing the Transmission of HIV in China
|
|
|
|
|
|
|
|
